ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,980Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 2456

$922K Total Retail Price of All Prescriptions

Rank: 50 out of 2456

621 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 621 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 621 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 13,188 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
SIMVASTATIN 1,059 803 1 2
LISINOPRIL 859 668 2 1
OMEPRAZOLE 812 511 3 3
METFORMIN HCL 727 512 4 11
FUROSEMIDE 572 476 5 8
ALENDRONATE SODIUM 469 387 6 19
WARFARIN SODIUM 448 398 7 9
AMLODIPINE BESYLATE 404 374 8 5
METOPROLOL SUCCINATE 361 267 9 13
METOPROLOL TARTRATE 354 277 10 10
LEVOTHYROXINE SODIUM 345 258 11 4
ATORVASTATIN CALCIUM 333 282 12 12
HYDROCODONE-ACETAMINOPHEN 323 212 S3 13 20
ZOLPIDEM TARTRATE 304 222 14 28
HYDROCHLOROTHIAZIDE 276 218 15 7
CITALOPRAM HBR 231 209 16 14
PROAIR HFA 229 105 17 22
TAMSULOSIN HCL 209 177 18 32
SERTRALINE HCL 207 178 19 21
ATENOLOL 205 174 20 6
GLIPIZIDE 197 154 21 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 192 162 22 41
GLYBURIDE 172 137 R 23 40
TRAZODONE HCL 161 136 24 17
PANTOPRAZOLE SODIUM 152 97 25 37
GABAPENTIN 151 84 26 16
ADVAIR DISKUS 148 88 27 36
KLOR-CON M20 146 119 28 69
POTASSIUM CHLORIDE 143 125 29 33
AZITHROMYCIN 142 94 30 60
ALLOPURINOL 141 139 31 27
FLUOXETINE HCL 131 59 32 45
PAROXETINE HCL 123 73 33 56
CLOPIDOGREL 122 107 34 55
DIGOXIN 117 103 35 49
CRESTOR 114 93 36 25
LANTUS 110 92 37 44
RANITIDINE HCL 109 69 38 31
NAPROXEN 108 75 39 109
GEMFIBROZIL 106 74 40 93
DONEPEZIL HCL 102 100 41 23
CIPROFLOXACIN HCL 101 79 42 87
TRAMADOL HCL 99 41 43 24
OXYCODONE-ACETAMINOPHEN 99 52 S2 43 35
SPIRIVA 87 46 45 43
MIRTAZAPINE 85 82 46 29
TRIAMTERENE-HCTZ 83 62 47 53
ISOSORBIDE MONONITRATE ER 83 76 47 48
LIPITOR 80 57 49 63
SINGULAIR 75 46 50 149
PREDNISONE 74 31 51 39
NEXIUM 73 61 52 80
PRAVASTATIN SODIUM 72 61 53 15
NAMENDA 72 69 53 42
PLAVIX 70 65 55 79
ACTOS 68 41 56 124
ALPRAZOLAM 67 60 57 141
TRICOR 67 25 57 163
MORPHINE SULFATE ER 67 13 S2 57 98
FINASTERIDE 66 66 60 66
INSULIN SYRINGE 64 37 61 72
METHYLPREDNISOLONE 64 40 61 229
SYMBICORT 63 19 63 138
AMITRIPTYLINE HCL 62 25 R 64 83
FENOFIBRATE 60 54 65 68
LOSARTAN POTASSIUM 59 47 66 18
CLONIDINE HCL 59 23 66 111
VENLAFAXINE HCL ER 58 19 68 92
QUETIAPINE FUMARATE 57 28 69 47
AMOX TR-POTASSIUM CLAVULANATE 57 32 69 194
DETROL LA 55 55 71 228
IBUPROFEN 55 24 71 52
OXYCODONE HCL 54 0 S2 73 38
VESICARE 53 48 74 205
FLUOCINONIDE 51 43 75 302
MONTELUKAST SODIUM 51 30 75 216
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.